Understanding the mechanisms underlying the AGR2-controlled release of 14-3-3ε and α-actinin 4 in response to stress conditions will contribute to the refinement of AGR2-targeting therapeutic strategies for cancers. This evidence concerns the gene AGR2 and cancer.